Search research articles
Contact Us
Filters
Showing results (661-670 of 743) with videos related to
Page
of 75
Sort By:
Oncogene
|
October 31, 2012
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
L J Monteiro, P Khongkow, M Kongsema, et al.
International Journal of Oncology
|
June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Richard E Francis, Stephen S Myatt, Janna Krol, et al.
BMC Public Health
|
December 21, 2024
Development of a territory-wide household-based composite index for measuring relative distribution of households by economic status in individual small areas throughout Hong Kong
Eva L H Tsui, Philip L H Yu, K F Lam, et al.
Cell Death & Disease
|
October 16, 2023
Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress
Bai Cui, Bin He, Yanping Huang, et al.
Molecular and Cellular Biology
|
August 2, 2006
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo
Inês Soeiro, Azim Mohamedali, Hanna M Romanska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2011
iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe
Lili Jiang, Michelle K Y Siu, Oscar G W Wong, et al.
Plos One
|
September 3, 2010
Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer
Jie Chen, Ana R Gomes, Lara J Monteiro, et al.
Oncogene
|
December 24, 2013
SUMOylation inhibits FOXM1 activity and delays mitotic transition
S S Myatt, M Kongsema, C W-Y Man, et al.
British Journal of Cancer
|
September 30, 2016
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
L Marzi, E Combes, N Vié, et al.
Plos One
|
November 21, 2014
Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance
Fung Zhao, Michelle K Y Siu, LiLi Jiang, et al.
Page
of 75
Search research articles
Search
Showing results (661-670 of 743) with videos related to
Sort By:
Page
of 75
Oncogene
|
October 31, 2012
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
L J Monteiro, P Khongkow, M Kongsema, et al.
International Journal of Oncology
|
June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Richard E Francis, Stephen S Myatt, Janna Krol, et al.
BMC Public Health
|
December 21, 2024
Development of a territory-wide household-based composite index for measuring relative distribution of households by economic status in individual small areas throughout Hong Kong
Eva L H Tsui, Philip L H Yu, K F Lam, et al.
Cell Death & Disease
|
October 16, 2023
Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress
Bai Cui, Bin He, Yanping Huang, et al.
Molecular and Cellular Biology
|
August 2, 2006
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo
Inês Soeiro, Azim Mohamedali, Hanna M Romanska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 20, 2011
iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe
Lili Jiang, Michelle K Y Siu, Oscar G W Wong, et al.
Plos One
|
September 3, 2010
Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer
Jie Chen, Ana R Gomes, Lara J Monteiro, et al.
Oncogene
|
December 24, 2013
SUMOylation inhibits FOXM1 activity and delays mitotic transition
S S Myatt, M Kongsema, C W-Y Man, et al.
British Journal of Cancer
|
September 30, 2016
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
L Marzi, E Combes, N Vié, et al.
Plos One
|
November 21, 2014
Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance
Fung Zhao, Michelle K Y Siu, LiLi Jiang, et al.
Page
of 75